150 related articles for article (PubMed ID: 37405385)
1. The MALAT1-breast cancer interplay: insights and implications.
Tufail M
Expert Rev Mol Diagn; 2023; 23(8):665-678. PubMed ID: 37405385
[TBL] [Abstract][Full Text] [Related]
2. LncRNA MALAT1 promotes breast cancer progression and doxorubicin resistance via regulating miR-570-3p.
Yue X; Wu WY; Dong M; Guo M
Biomed J; 2021 Dec; 44(6 Suppl 2):S296-S304. PubMed ID: 35410813
[TBL] [Abstract][Full Text] [Related]
3. The expression of lncRNA-MALAT1 in breast cancer patients and its influences on prognosis.
Sun Z; Liu J; Liu J
Cell Mol Biol (Noisy-le-grand); 2020 Jun; 66(3):72-78. PubMed ID: 32538750
[TBL] [Abstract][Full Text] [Related]
4. Clinical Significance of Long Non-coding RNA MALAT1 Expression in Tissue and Serum of Breast Cancer.
Miao Y; Fan R; Chen L; Qian H
Ann Clin Lab Sci; 2016 Jul; 46(4):418-24. PubMed ID: 27466303
[TBL] [Abstract][Full Text] [Related]
5. Targeting long non-coding RNA MALAT1 reverses cancerous phenotypes of breast cancer cells through microRNA-561-3p/TOP2A axis.
Hajibabaei S; Nafissi N; Azimi Y; Mahdian R; Rahimi-Jamnani F; Valizadeh V; Rafiee MH; Azizi M
Sci Rep; 2023 May; 13(1):8652. PubMed ID: 37244966
[TBL] [Abstract][Full Text] [Related]
6. Screening of miRNAs associated with lymph node metastasis in Her-2-positive breast cancer and their relationship with prognosis.
Qiao EQ; Yang HJ; Zhang XP
J Zhejiang Univ Sci B; 2020 Jun; 21(6):495-508. PubMed ID: 32478495
[TBL] [Abstract][Full Text] [Related]
7. lncRNA MALAT1/miR‑26a/26b/ST8SIA4 axis mediates cell invasion and migration in breast cancer cell lines.
Wang N; Cao S; Wang X; Zhang L; Yuan H; Ma X
Oncol Rep; 2021 Aug; 46(2):. PubMed ID: 34278507
[TBL] [Abstract][Full Text] [Related]
8. MALAT1 promotes angiogenesis of breast cancer.
Huang XJ; Xia Y; He GF; Zheng LL; Cai YP; Yin Y; Wu Q
Oncol Rep; 2018 Nov; 40(5):2683-2689. PubMed ID: 30226550
[TBL] [Abstract][Full Text] [Related]
9. Knockdown of long non-coding RNA metastasis associated lung adenocarcinoma transcript 1 inhibits the proliferation and migration of bladder cancer cells by modulating the microRNA-34a/cyclin D1 axis.
Liu Y; Gao S; Du Q; Zhao Q
Int J Mol Med; 2019 Jan; 43(1):547-556. PubMed ID: 30387807
[TBL] [Abstract][Full Text] [Related]
10. Aberrant KDM5B expression promotes aggressive breast cancer through MALAT1 overexpression and downregulation of hsa-miR-448.
Bamodu OA; Huang WC; Lee WH; Wu A; Wang LS; Hsiao M; Yeh CT; Chao TY
BMC Cancer; 2016 Feb; 16():160. PubMed ID: 26917489
[TBL] [Abstract][Full Text] [Related]
11. Suppression of Long Non-Coding RNA Metastasis-Associated Lung Adenocarcinoma Transcript 1 (MALAT1) Potentiates Cell Apoptosis and Drug Sensitivity to Taxanes and Adriamycin in Breast Cancer.
Yu J; Jin T; Zhang T
Med Sci Monit; 2020 Jul; 26():e922672. PubMed ID: 32623440
[TBL] [Abstract][Full Text] [Related]
12. Long non-coding RNA MALAT1 regulates BLCAP mRNA expression through binding to miR-339-5p and promotes poor prognosis in breast cancer.
Zheng L; Zhang Y; Fu Y; Gong H; Guo J; Wu K; Jia Q; Ding X
Biosci Rep; 2019 Feb; 39(2):. PubMed ID: 30683807
[TBL] [Abstract][Full Text] [Related]
13. Long non-coding RNA MALAT1 promotes proliferation and invasion via targeting miR-129-5p in triple-negative breast cancer.
Zuo Y; Li Y; Zhou Z; Ma M; Fu K
Biomed Pharmacother; 2017 Nov; 95():922-928. PubMed ID: 28915533
[TBL] [Abstract][Full Text] [Related]
14. Oncogenic signaling pathway-related long non-coding RNAs for predicting prognosis and immunotherapy response in breast cancer.
Li H; Liu H; Hao Q; Liu X; Yao Y; Cao M
Front Immunol; 2022; 13():891175. PubMed ID: 35990668
[TBL] [Abstract][Full Text] [Related]
15. MALAT1: A key regulator in lung cancer pathogenesis and therapeutic targeting.
Bhat AA; Afzal O; Afzal M; Gupta G; Thapa R; Ali H; Hassan Almalki W; Kazmi I; Alzarea SI; Saleem S; Samuel VP; Gubbiyappa SK; Subramaniyan V
Pathol Res Pract; 2024 Jan; 253():154991. PubMed ID: 38070223
[TBL] [Abstract][Full Text] [Related]
16. High expression of long non-coding RNA MALAT1 in breast cancer is associated with poor relapse-free survival.
Wang Z; Katsaros D; Biglia N; Shen Y; Fu Y; Loo LWM; Jia W; Obata Y; Yu H
Breast Cancer Res Treat; 2018 Sep; 171(2):261-271. PubMed ID: 29845475
[TBL] [Abstract][Full Text] [Related]
17. Association analyses of genetic variants in long non-coding RNA MALAT1 with breast cancer susceptibility and mRNA expression of MALAT1 in Chinese Han population.
Peng R; Luo C; Guo Q; Cao J; Yang Q; Dong K; Wang S; Wang K; Song C
Gene; 2018 Feb; 642():241-248. PubMed ID: 29146194
[TBL] [Abstract][Full Text] [Related]
18. Baicalin suppresses the migration and invasion of breast cancer cells via the TGF-β/lncRNA-MALAT1/miR-200c signaling pathway.
Li J; Liu H; Lin Q; Chen H; Liu L; Liao H; Cheng Y; Zhang X; Wang Z; Shen A; Chen G
Medicine (Baltimore); 2022 Nov; 101(46):e29328. PubMed ID: 36401368
[TBL] [Abstract][Full Text] [Related]
19. The interaction between MALAT1 target, miR-143-3p, and RALGAPA2 is affected by functional SNP rs3827693 in breast cancer.
Fattahi Dolatabadi N; Dehghani A; Shahand E; Yazdanshenas M; Tabatabaeian H; Zamani A; Azadeh M; Ghaedi K
Hum Cell; 2020 Oct; 33(4):1229-1239. PubMed ID: 32880825
[TBL] [Abstract][Full Text] [Related]
20. Functional and prognostic significance of long non-coding RNA MALAT1 as a metastasis driver in ER negative lymph node negative breast cancer.
Jadaliha M; Zong X; Malakar P; Ray T; Singh DK; Freier SM; Jensen T; Prasanth SG; Karni R; Ray PS; Prasanth KV
Oncotarget; 2016 Jun; 7(26):40418-40436. PubMed ID: 27250026
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
